TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.640
+0.090 (5.81%)
At close: Mar 4, 2026, 4:00 PM EST
1.610
-0.030 (-1.83%)
After-hours: Mar 4, 2026, 7:11 PM EST
TuHURA Biosciences Employees
TuHURA Biosciences had 19 employees as of December 31, 2024. The number of employees increased by 18 or 1,800.00% compared to the previous year.
Employees
19
Change (1Y)
18
Growth (1Y)
1,800.00%
Revenue / Employee
n/a
Profits / Employee
-$1,541,833
Market Cap
99.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 19 | 18 | 1,800.00% |
| Dec 31, 2023 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 188 |
| Seer, Inc. | 134 |
| aTyr Pharma | 65 |
| PMV Pharmaceuticals | 47 |
| Pyxis Oncology | 44 |
| Biomea Fusion | 42 |
| Cognition Therapeutics | 28 |
| iBio, Inc. | 20 |
HURA News
- 5 days ago - TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 8 days ago - TuHURA Biosciences Announces Participation in Upcoming Investor Conferences - PRNewsWire
- 15 days ago - TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers - PRNewsWire
- 20 days ago - TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - PRNewsWire
- 4 weeks ago - TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma - PRNewsWire
- 2 months ago - TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - PRNewsWire
- 2 months ago - TuHURA Biosciences Provides Corporate Update Following Recent Financing - PRNewsWire
- 3 months ago - TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering - PRNewsWire